Professional
Added to YB: 2024-10-16
Pitch date: 2024-09-30
IDT.AX [bullish]
IDT Australia Limited
-52.17%
current return
Author Info
No bio for this author
Company Info
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States.
Market Cap
$43.0M
Pitch Price
$0.12
Price Target
0.23 (+315%)
Dividend
N/A
EV/EBITDA
-9.07
P/E
-6.43
EV/Sales
3.32
Sector
Pharmaceuticals
Category
value
Sandon Capital Activist Fund Portfolio Holding: IDT Australia Limited
IDT.AX: Underutilized pharma assets in Melbourne. New mgmt focuses on API, Advanced Therapies (mRNA, ADC), cannabis & psychedelics. Recent contract wins support positive cash flow by end 2024. 15c/share offer from Myndbio. Replacement value $88.8M (~23c/share) excluding licenses. Potential upside.
Read full article (2 min)